Feedback / Questions
WVE-120102 - Wave Life Sciences, Takeda
WVE-120102: Regulatory approval for Huntington's disease in FY2025/FY2026
(Takeda)
-
Aug 1, 2020 -
Q1 FY2020 Results
Regulatory
•
Huntington's Disease
https://www.takeda.com/4a2679/siteassets/system/investors/report/quarterlyannouncements/fy2020/qr2020_q1_p01_en.pdf
Aug 1, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious